NIA Symposium Reveals Critical Gaps in Aging Biomarker Development
Leading researchers identify key challenges in validating aging biomarkers for clinical use, emphasizing need for longitudinal studies.
Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
621 articles
Leading researchers identify key challenges in validating aging biomarkers for clinical use, emphasizing need for longitudinal studies.
New research explores how epigenetic modifications control the aging process and potential therapeutic targets.
New study reveals mitochondrial NAD+ concentration, not total cellular levels, determines how fast the liver can regenerate after injury.
Comprehensive review reveals emerging clinical evidence for NAD+ precursors in treating age-related diseases and cognitive decline.
DNA methylation patterns reveal that patients with faster biological aging experience more rapid vision loss from glaucoma.
Study of 1,014 adults finds GrimAge epigenetic clock most accurately links biological aging to physical performance from age 20-104.
Analysis of 1,942 people shows GrimAge and GrimAge2 epigenetic clocks outperform other aging biomarkers at predicting mortality.
Leading NAD+ researcher Dr. Charles Brenner shares breakthrough insights on cellular energy, aging, and practical longevity strategies.

Practical longevity strategies across decades of life, from DEXA interpretation to mTOR concerns with high protein intake.
Researchers used advanced genetic screens to identify long noncoding RNAs that regulate senescence, finding therapeutic targets for age-related diseases.
Researchers create detailed spatial atlas revealing cellular changes in aging breast tissue using advanced mapping technology.
Novel therapy using apoptotic vesicles carrying PKM2 eliminates senescent cells and reduces chronic gum inflammation in mice.